| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |